Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study

NCT02605837 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT02605837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02605837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
December 7, 2015
Completion date
February 15, 2019
Enrollment
318 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis (eoe)